ARWR

Arrowhead Pharmaceuticals Stock Analysis

AI Rating

Fair
  • Quality0/10
  • Growth↑ 7/10
  • Value↓ 1/10
Arrowhead Pharmaceuticals sales and earnings growth
ARWR Growth
Good
  • Revenue Y/Y↓ 2.73%
  • EPS Y/Y↓ -58.09%
  • FCF Y/Y↓ -630.14%
Arrowhead Pharmaceuticals gross and profit margin trends
ARWR Profitability
Fair
  • Gross margin ↑ 100.00%
  • EPS margin↓ -48.40%
  • ROIC 5Y↓ -20.37%
Arrowhead Pharmaceuticals net debt vs free cash flow
ARWR Risk
Fair
  • Debt / Equity↑ 2.3
  • Debt / FCF↑ 23.3
  • Interest coverage↓ -2.0

Arrowhead Pharmaceuticals stock volatility is higher than the overall market. We give it a Fair risk rating.

↗ More Biotechnology stocks